---
figid: PMC9281252__12032_2022_1749_Fig4_HTML
figtitle: 'Molecular perspective on targeted therapy in breast cancer: a review of
  current status'
organisms:
- Homo sapiens
pmcid: PMC9281252
filename: 12032_2022_1749_Fig4_HTML.jpg
figlink: /pmc/articles/PMC9281252/figure/Fig4/
number: F4
caption: Alpelisib inhibits the class I p110a isoform and Everolimus inhibits the
  mTORC1 complex, thereby preventing downstream signaling of PI3K/Akt/mTOR signaling
  pathway. IR insülin receptor, IGF-1R insülin like growth factor 1 receptor, HER
  human epidermal growth factor receptor, GRB2 growth factor receptor-bound protein
  2, MEK MAP kinase kinase, PIP2 phosphatidylinositol 4,5-bisphosphate, PIP3 phosphatidylinositol
  3,4,5-triphosphate, PTEN tumor suppressor phosphatase and tensin homolog deleted
  on chromosome 10, PDK1 3-Phosphoinositide-dependent protein kinase-1, TSC tuberous
  sclerosis complex, mTORC1 mTOR complex 1 (adapted from “PI3K/Akt, RAS/MAPK, JAK/STAT
  Signaling”, by BioRender.com (2022). Retrieved from https://app.biorender.com/biorender-templates)
papertitle: 'Molecular perspective on targeted therapy in breast cancer: a review
  of current status.'
reftext: Busra Demir Cetinkaya, et al. Med Oncol. 2022;39(10):149.
year: '2022'
doi: 10.1007/s12032-022-01749-1
journal_title: Medical Oncology (Northwood, London, England)
journal_nlm_ta: Med Oncol
publisher_name: Springer US
keywords: Breast cancer | Targeted therapy | PI3K/Akt/mTOR pathway inhibitors | CDK4/6
  inhibitors | PARP inhibitors
automl_pathway: 0.9091615
figid_alias: PMC9281252__F4
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC9281252__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9281252__12032_2022_1749_Fig4_HTML.html
  '@type': Dataset
  description: Alpelisib inhibits the class I p110a isoform and Everolimus inhibits
    the mTORC1 complex, thereby preventing downstream signaling of PI3K/Akt/mTOR signaling
    pathway. IR insülin receptor, IGF-1R insülin like growth factor 1 receptor, HER
    human epidermal growth factor receptor, GRB2 growth factor receptor-bound protein
    2, MEK MAP kinase kinase, PIP2 phosphatidylinositol 4,5-bisphosphate, PIP3 phosphatidylinositol
    3,4,5-triphosphate, PTEN tumor suppressor phosphatase and tensin homolog deleted
    on chromosome 10, PDK1 3-Phosphoinositide-dependent protein kinase-1, TSC tuberous
    sclerosis complex, mTORC1 mTOR complex 1 (adapted from “PI3K/Akt, RAS/MAPK, JAK/STAT
    Signaling”, by BioRender.com (2022). Retrieved from https://app.biorender.com/biorender-templates)
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - KRAS
  - HRAS
  - NRAS
  - XYLT2
  - SOS1
  - SOS2
  - GRB2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MTG1
  - IGF1R
  - PIK3R1
  - PIK3R2
  - ARHGEF7
  - CBFA2T2
  - PPP1R13B
  - PPP1R12C
  - CUX1
  - SART3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PTEN
  - RHEB
  - RHEBP1
  - PDK1
  - PDPK1
  - AKT1
  - AKT2
  - AKT3
  - TSC2
  - TSC1
  - CCL26
  - MTOR
  - RPTOR
---
